UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Critical care (London, England), 2019-11, Vol.23 (1), p.374-374, Article 374

2019

Volltextzugriff (PDF)

Adrenal function in sepsis: The retrospective Corticus cohort study

Critical care medicine, 2007-04, Vol.35 (4), p.1012-1018

2007

Volltextzugriff (PDF)

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

The New England journal of medicine, 2001-03, Vol.344 (10), p.699-709

2001

Volltextzugriff (PDF)

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

The New England journal of medicine, 2004-08, Vol.351 (9), p.884-892

2004

Volltextzugriff (PDF)

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Critical care (London, England), 2020-06, Vol.24 (1), p.289-289, Article 289

2020

Volltextzugriff (PDF)

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Critical care (London, England), 2020-07, Vol.24 (1), p.410-410, Article 410

2020

Volltextzugriff (PDF)

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

American journal of respiratory and critical care medicine, 2021-11, Vol.204 (9), p.1024-1034

2021

Volltextzugriff (PDF)

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Critical care (London, England), 2004-04, Vol.8 (2), p.R82-R90, Article R82

2004

Volltextzugriff (PDF)

Convalescent Plasma for Covid-19-Induced ARDS. Reply

The New England journal of medicine, 2024-01, Vol.390 (4), p.386-386

2024

Volltextzugriff (PDF)

Aerosol delivery during invasive mechanical ventilation: a systematic review

Critical care (London, England), 2017-10, Vol.21 (1), p.264-264, Article 264

2017

Volltextzugriff (PDF)

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Critical care medicine, 2018-09, Vol.46 (9), p.1436-1443

2018

Volltextzugriff (PDF)

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

Critical care (London, England), 2018-01, Vol.22 (1), p.8-8, Article 8

2018

Volltextzugriff (PDF)

Immunotherapies for COVID-19: lessons learned from sepsis

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.946-949

2020

Volltextzugriff (PDF)

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

Intensive care medicine, 2020-07, Vol.46 (7), p.1425-1437

2020

Volltextzugriff (PDF)

Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop

Intensive care medicine, 2020-05, Vol.46 (5), p.930-942

2020

Volltextzugriff (PDF)

Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients

The New England journal of medicine, 2023-10, Vol.389 (17), p.1590-1600

2023

Volltextzugriff (PDF)

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-10, Vol.322 (15), p.1476

2019

Volltextzugriff (PDF)

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Critical care medicine, 2004-02, Vol.32 (2), p.332-341

2004

Volltextzugriff (PDF)

Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition

Critical care (London, England), 2008-01, Vol.12 Suppl 6 (Suppl 6), p.S4-S4

Laterre, Pierre-Francois

2008

Volltextzugriff (PDF)

Improving the management of severe acute pancreatitis: The new guidelines from the French Society of Anaesthesia and Intensive Care Medicine

Anaesthesia critical care & pain medicine, 2022-06, Vol.41 (3), p.101103-101103, Article 101103

2022

Volltextzugriff (PDF)

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

Critical care (London, England), 2010-01, Vol.14 (4), p.R126-R126, Article R126

2010

Volltextzugriff (PDF)

Breakthrough in cardiac arrest: reports from the 4th Paris International Conference

Annals of Intensive Care, 2015-09, Vol.5 (1), p.22-22, Article 22

2015

Volltextzugriff (PDF)

Serum uric acid, disease severity and outcomes in COVID-19

Critical care (London, England), 2021-06, Vol.25 (1), p.1-212, Article 212

2021

Volltextzugriff (PDF)

Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

Shock (Augusta, Ga.), 2018-04, Vol.49 (4), p.385-392

2018

Volltextzugriff (PDF)

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)

BMJ open, 2019-02, Vol.9 (2), p.e024475

2019

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR Complete Journals

ThemaAged

ThemaGeneral & Internal Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(92)

Sprache

Englisch
(92)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Adrenal function in sepsis: The retrospective Corticus cohort study

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Convalescent Plasma for Covid-19-Induced ARDS. Reply

Aerosol delivery during invasive mechanical ventilation: a systematic review

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

Immunotherapies for COVID-19: lessons learned from sepsis

Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial

Contemporary strategies to improve clinical trial design for critical care research: insights from the First Critical Care Clinical Trialists Workshop

Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition

Improving the management of severe acute pancreatitis: The new guidelines from the French Society of Anaesthesia and Intensive Care Medicine

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

Breakthrough in cardiac arrest: reports from the 4th Paris International Conference

Serum uric acid, disease severity and outcomes in COVID-19

Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)

Aktive Filter

Suchergebnisse filtern